RBL LLC launches Duracyte, advancing living pharmacy platform in Houston's growing biotech hub

HOUSTON, April 15, 2026 /PRNewswire/ -- RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies, today announced the launch of Duracyte, a biotechnology company commercializing a pioneering class of implantable "biohybrid pharmacy" devices designed to produce therapeutic proteins continuously inside the human body